177Lu-DOTATATE for Recurrent Meningioma

Clinical trial NCT06326190 · RECRUITING

Trial details

NCT number: NCT06326190
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Meningioma

Start date: 2025-03-10
Primary completion: 2027-04-14
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.